NW
ABBV icon

Naviter Wealth’s AbbVie ABBV Stock Holding History

Naviter Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.64M Buy
16,738
+325
+2% +$72.1K 0.45% 43
2025
Q4 		$3.75M Sell
16,413
-3,322
-17% -$757K 0.49% 43
2025
Q3 		$4.57M Buy
19,735
+885
+5% +$180K 0.53% 38
2025
Q2 		$3.5M Buy
18,850
+51
+0.3% +$9.48K 0.43% 53
2025
Q1 		$3.86M Sell
18,799
-257
-1% -$50K 0.47% 52
2024
Q4 		$3.39M Buy
19,056
+5,736
+43% +$1.05M 0.41% 58
2024
Q3 		$2.63M Sell
13,320
-741
-5% -$138K 0.37% 68
2024
Q2 		$2.41M Buy
14,061
+1,082
+8% +$179K 0.36% 77
2024
Q1 		$2.36M Buy
12,979
+2,034
+19% +$351K 0.39% 72
2023
Q4 		$1.7M Buy
10,945
+1,365
+14% +$199K 0.34% 80
2023
Q3 		$1.43M Buy
9,580
+868
+10% +$127K 0.34% 73
2023
Q2 		$1.17M Buy
8,712
+1,334
+18% +$196K 0.3% 87
2023
Q1 		$1.18M Buy
7,378
+68
+0.9% +$10.4K 0.41% 65
2022
Q4 		$1.09M Buy
7,310
+887
+14% +$136K 0.3% 83
2022
Q3 		$862K Buy
6,423
+737
+13% +$106K 0.35% 61
2022
Q2 		$871K Buy
+5,686
New +$869K 0.36% 62

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Naviter Wealth's ABBV Position: Q1 2026 in Review

Naviter Wealth increased its AbbVie (ABBV) stake by 2% in Q1 2026, buying an estimated $72.1K and bringing the position to 16,738 shares worth $3.64M. The position accounts for 0.45% of the portfolio, ranked #43.

Naviter Wealth first reported a position in ABBV in Q2 2022 and has held it in 16 quarters since. The position peaked at $4.57M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Naviter Wealth held 16,738 shares of AbbVie worth $3.64M as of Q1 2026.
  • Naviter Wealth bought 325 AbbVie shares in Q1 2026, an estimated $72.1K.
  • AbbVie made up 0.45% of Naviter Wealth's portfolio in Q1 2026, its #43 holding.
  • Naviter Wealth first reported a position in AbbVie in Q2 2022 and has held it in 16 quarters since.
  • Naviter Wealth's AbbVie position peaked at $4.57M in Q3 2025.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.